AIEgen Nanoparticles of Arylamino Fumaronitrile Derivative with High Near-Infrared Emission for Two-Photon Imaging and in Vivo Cell Tracking

Imaging technology in tracking the intravital fate of transplanted stem cells

Stem cell therapy emerges as a promising alternative strategy for diseases that currently lack effective treatment options. Investigating the pharmacokinetic properties of stem cells, such as their survival, migration, differentiation, and engraftment dynamics, offers valuable insights for elucidating therapeutic mechanisms, refining treatment protocols, and ultimately enhancing therapeutic efficacy. Moreover, the pharmaceutical research of stem cell products is an essential prerequisite for regulatory approval. This contribution focus on the development of advanced imaging technologies for noninvasive monitoring the intravital fate of implanted stem cells, as well as the advantages and challenges of each imaging approach. Through comprehensive analysis of stem cell metabolic pathway, we identify critical barriers to clinical translation of stem cell therapy. In the end, we discuss future perspectives and opportunities in stem cell tracking and functional assessment.

Hydrogel and nanoparticle carriers for kidney disease therapy: trends and recent advancements

Achieving local therapeutic agent concentration in the kidneys through traditional systemic administration routes have associated concerns with off-target drug effects and toxicity. Additionally, kidney diseases are often accompanied by co-morbidities in other major organs, which negatively impacts drug metabolism and clearance. To circumvent these issues, kidney-specific targeting of therapeutics aims to achieve the delivery of controlled doses of therapeutic agents, such as drugs, nucleic acids, peptides, or proteins, to kidney tissues in a safe and efficient manner. Current carrier material approaches implement macromolecular and polyplex hydrogel constructs, prodrug strategies, and nanoparticle (NP)-based delivery technologies. In the context of multidisciplinary and cross-discipline innovations, the medical and bioengineering research fields have facilitated the rapid development of kidney-targeted therapies and carrier materials. In this review, we summarize the current trends and recent advancements made in the development of carrier materials for kidney disease targeted therapies, specifically hydrogel and NP-based strategies for acute kidney disease, chronic kidney disease, and renal cell carcinoma. Additionally, we discuss the current limitations in carrier materials and their delivery mechanisms.

Regioisomer-manipulating thio-perylenediimide nanoagents for photothermal/photodynamic theranostics

Thionated perylenediimides (PDIs) can potentially generate thermal and reactive oxygen species and thus can be used as theranostic agents for photothermal/photodynamic therapy. Herein, thionated cis-/trans-isomer PDI-CS and PDI-TS were designed and prepared to investigate thionation engineering on therapeutic performance. The results revealed that the photodynamic performance is less associated with the positon of sulfur atoms. By contrast, trans-isomer PDI-TS showed a photothermal conversion efficiency of up to 58.4%, which was 40% higher than that of PDI-CS (∼41.6%). An in vitro half-maximal inhibitory concentration of ∼7.78 μg mL-1 was achieved for PDI-TS, which was 1.7-fold smaller than that of PDI-CS, strongly reasserting the regioisomer-modulated phototheranostic performance. Notably, the strong π-π and CS interactions in PDI-TS nanoagents are essential factors attributed to their excellent photothermal performance, indicating that the optimization of non-bonding interactions is an ingenious way to improve phototheranostic performance. This work provides a facile means of creating thio-perylenediimides that possess excellent antitumor properties and a novel proof of concept to improve therapeutic performance through the optimization of non-bonding interactions.

Synergistic non-bonding interactions based on diketopyrrolo-pyrrole for elevated photoacoustic imaging-guided photothermal therapy

Synergistic non-bonding interactions in fluorine and chalcogen-substituted diketopyrrolopyrrole nanoagents for elevated photoacoustic imaging-guided photothermal therapy.

Terselenophene Regioisomer Conjugated Polymer Materials for High-Performance Cancer Phototheranostics

Molecular isomerization is a fundamental issue in the development of functional materials, with a crucial impact on photophysical properties. However, up to now, their effect on photothermal conversion is rarely investigated. Here, two near-infrared (NIR)-absorbing regioisomer conjugated polymers integrated with cis/trans-terselenophenes are designed and synthesized as efficient photothermal agents to enhance cancer phototheranostics. It is demonstrated that enhanced quinoidal resonance of trans-terselenophenes allows the resulting trans-CP to possess more planar backbone to further increase the effective conjugation length and result in the strong absorption spectra at 808 nm. Characterization of photophysical properties has proved that the photothermal conversion efficiency of trans-CP nanoparticles is up to 61.4%, and they are 210% as strong as cis-CP nanoparticles (29.4%). Further in vitro and in vivo works demonstrate efficient photothermal therapeutic effects with the guidance of photoacoustic imaging. This work affords a new understanding of the molecular isomerization into the development of conjugated materials for high-performance cancer phototheranostics.